: The AMEDEO Literature Guide

Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription

Articles published in Breast Cancer Res Treat
Retrieve available abstracts of 471 articles:
HTML format

Single Articles

June 2009

LIU Y , Diamant AL, Thind A, Maly RC, et al
Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

FREEDMAN O , Amir E, Dranitsaris G, Napolskikh J, et al
Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

DEY S , Soliman AS, Hablas A, Seifeldin IA, et al
Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

WENZEL J , Zeisig R, Haider W, Habedank S, et al
Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

DORJGOCHOO T , Kallianpur A, Zheng Y, Gu K, et al
Impact of menopausal symptoms on quality of life 6 months after systemic breast cancer treatment: results from the Shanghai Breast Cancer Survival Study.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

TAYLOR VH , Misra M, Mukherjee SD
Is red meat intake a risk factor for breast cancer among premenopausal women?
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

SUN RC , Fadia M, Dahlstrom JE, Parish CR, et al
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ZHENG YL , Ambrosone C, Byrne C, Davis W, et al
Telomere length in blood cells and breast cancer risk: investigations in two case-control studies.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

BARROSO E , Pita G, Arias JI, Menendez P, et al
The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

DE AMICIS F , Thirugnansampanthan J, Cui Y, Selever J, et al
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

SPARANO JA , Hortobagyi GN, Gralow JR, Perez EA, et al
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

NICHOLS M , Cheng P, Liu Y, Kanterewicz B, et al
Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MAURI D , Valachis A, Polyzos IP, Polyzos NP, et al
Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metanalysis.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

BAYET-ROBERT M , Morvan D, Chollet P, Barthomeuf C, et al
Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MCCAFFERTY MP , McNeill RE, Miller N, Kerin MJ, et al
Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

AMEZIANE N , van den Ouweland AM, Adank MA, Vijzelaar RN, et al
Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles

HABASHY HO , Powe DG, Rakha EA, Ball G, et al
The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

DRANITSARIS G , Coleman R, Gradishar W
nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

WU MF , Hilsenbeck SG, Tham YL, Kramer R, et al
The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

YU KD , Di GH, Fan L, Hu Z, et al
Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2.
Breast Cancer Res Treat. 2009.
PubMed Related articles

ONITILO AA , McCarty CA, Wilke RA, Glurich I, et al
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy.
Breast Cancer Res Treat. 2009;115:643-50.
PubMed Related articles Abstract available

SUGARMAN S , Wasserheit C, Hodgman E, Coglianese M, et al
A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma.
Breast Cancer Res Treat. 2009;115:609-12.
PubMed Related articles Abstract available

May 2009

BARGINEAR MF , Leung M, Budman DR
The hedgehog pathway as a therapeutic target for treatment of breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

SMITH JW 2ND , McIntyre KJ, Acevedo PV, Encarnacion CA, et al
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

BILLAM M , Sobolewski MD, Davidson NE
Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

KARN T , Metzler D, Ruckhaberle E, Hanker L, et al
Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

LIPPMAN ME , Ethier S, Hayes DF
Cost-effective analyses in Breast Cancer Research and Treatment.
Breast Cancer Res Treat. 2009.
PubMed Related articles

MALY RC , Liu Y, Leake B, Thind A, et al
Treatment-related symptoms among underserved women with breast cancer: the impact of physician-patient communication.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MITCHELL KW , Carey LA, Peppercorn J
Reporting of race and ethnicity in breast cancer research: room for improvement.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

OGUNLEYE AA , Xue F, Michels KB
Green tea consumption and breast cancer risk or recurrence: a meta-analysis.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

GERGER A , Renner W, Langsenlehner T, Hofmann G, et al
Association of interleukin-10 gene variation with breast cancer prognosis.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

LAHUSEN T , Henke RT, Kagan BL, Wellstein A, et al
The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

FESSLER SP , Wotkowicz MT, Mahanta SK, Bamdad C, et al
MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

BRINKMAN A , de Jong D, Tuinman S, Azaouagh N, et al
The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

April 2009

WANG X , Fredericksen ZS, Vierkant RA, Kosel ML, et al
Association of genetic variation in mitotic kinases with breast cancer risk.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

PAGLIA LL , Lauge A, Weber J, Champ J, et al
ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

COLLERAN G , McInerney N, Rowan A, Barclay E, et al
The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ROWLAND JH , Meyerowitz BE, Crespi CM, Leedham B, et al
Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

PEATE M , Meiser B, Hickey M, Friedlander M, et al
The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

YE C , Shu XO, Pierce L, Wen W, et al
Mutations in the mitochondrial DNA D-loop region and breast cancer risk.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

OLSON JE , Wang X, Goode EL, Pankratz VS, et al
Variation in genes required for normal mitosis and risk of breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

CHEN Y , Huang K, Chen KE, Walker AM, et al
Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor alpha in T47D breast cancer cells.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

WALKER MS , Schwartzberg LS, Stepanski EJ, Fortner BV, et al
A retrospective study of quality of life in a community sample of patients with early stage breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

STOPE MB , Popp SL, Knabbe C, Buck MB, et al
Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MUJAHID MS , Janz NK, Hawley ST, Griggs JJ, et al
The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

FOURKALA EO , Hauser-Kronberger C, Apostolidou S, Burnell M, et al
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

HAN W , Kang SY
Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

WANG J , Xia TS, Liu XA, Ding Q, et al
A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

LANCASHIRE LJ , Powe DG, Reis-Filho JS, Rakha E, et al
A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

CHAKRABORTY AK , Welsh A, Digiovanna MP
Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

March 2009

BRINTON LA , Carreon JD, Gierach GL, McGlynn KA, et al
Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

OSTRAKHOVITCH EA , Li SS
NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

GRANN VR , Patel P, Bharthuar A, Jacobson JS, et al
Breast cancer-related preferences among women with and without BRCA mutations.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MARTIN MG , Welch JS, Luo J, Ellis MJ, et al
Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

KIM HS , Park YH, Park MJ, Chang MH, et al
Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MULLER P , Crofts JD, Newman BS, Bridgewater LC, et al
SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ELLIS GK , Bone HG, Chlebowski R, Paul D, et al
Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

FU J , Weise AM, Falany JL, Falany CN, et al
Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

CHEN DT , Nasir A, Venkataramu C, Fulp W, et al
Evaluation of malignancy-risk gene signature in breast cancer patients.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

TORRES LACOMBA M , Mayoral Del Moral O, Coperias Zazo JL, Yuste Sanchez MJ, et al
Axillary web syndrome after axillary dissection in breast cancer: a prospective study.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

FU DY , Wang ZM, Li-Chen, Wang BL, et al
Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

HAMEL S , Bouchard A, Ferrario C, Hassan S, et al
Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ABRAHAM L , Geller BM, Yankaskas BC, Bowles EJ, et al
Accuracy of self-reported breast cancer among women undergoing mammography.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

WHITTEMORE AS , Stearman B, Venne V, Halpern J, et al
No evidence of familial correlation in breast cancer metastasis.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MAYER EL , Partridge AH, Harris LN, Gelman RS, et al
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

SUN Y , Urquidi V, Goodison S
Derivation of molecular signatures for breast cancer recurrence prediction using a two-way validation approach.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

THOMAS NB , Hutcheson IR, Campbell L, Gee J, et al
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MAIORANO E , Regan MM, Viale G, Mastropasqua MG, et al
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

CZARNECKA AM , Krawczyk T, Zdrozny M, Lubinski J, et al
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

AKENS MK , Hardisty MR, Wilson BC, Schwock J, et al
Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin).
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

LUBINSKI J , Korzen M, Gorski B, Cybulski C, et al
Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology.
Breast Cancer Res Treat. 2009;114:121-6.
PubMed Related articles Abstract available

MICHELS KB , Willett WC
The Women's Health Initiative Randomized Controlled Dietary Modification Trial: a post-mortem.
Breast Cancer Res Treat. 2009;114:1-6.
PubMed Related articles Abstract available

BATCHELDER AJ , Gordon-Weeks AN, Walker RA
Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts.
Breast Cancer Res Treat. 2009;114:63-9.
PubMed Related articles Abstract available

PEIXOTO A , Santos C, Rocha P, Pinheiro M, et al
The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal.
Breast Cancer Res Treat. 2009;114:31-8.
PubMed Related articles Abstract available

PETIT JY , Veronesi U, Rey P, Rotmensz N, et al
Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases.
Breast Cancer Res Treat. 2009;114:97-101.
PubMed Related articles Abstract available

CREIGHTON CJ , Kent Osborne C, van de Vijver MJ, Foekens JA, et al
Molecular profiles of progesterone receptor loss in human breast tumors.
Breast Cancer Res Treat. 2009;114:287-99.
PubMed Related articles Abstract available

RAKHA EA , Gill MS, El-Sayed ME, Khan MM, et al
The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology.
Breast Cancer Res Treat. 2009;114:243-50.
PubMed Related articles Abstract available

KIM HJ , Son BH, Park EW, Lim WS, et al
Axillary recurrence after negative sentinel lymph node biopsy.
Breast Cancer Res Treat. 2009;114:301-5.
PubMed Related articles Abstract available

RICHARDS GM , Tome WA, Robins HI, Stewart JA, et al
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
Breast Cancer Res Treat. 2009;114:307-13.
PubMed Related articles Abstract available

NIEVES-ALICEA R , Colburn NH, Simeone AM, Tari AM, et al
Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression.
Breast Cancer Res Treat. 2009;114:203-9.
PubMed Related articles Abstract available

February 2009

CAMPA D , McKay J, Sinilnikova O, Husing A, et al
Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ZHANG M , Yang H, Holman CD
Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

JONES RL , Salter J, A'hern R, Nerurkar A, et al
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

YU KD , Di GH, Fan L, Shao ZM, et al
Test of Hardy-Weinberg equilibrium in breast cancer case-control studies: an issue may influence the conclusions.
Breast Cancer Res Treat. 2009.
PubMed Related articles

LEMIEUX J , Amireault C, Provencher L, Maunsell E, et al
Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ARISAN ED , Kutuk O, Tezil T, Bodur C, et al
Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

HABASHY HO , Powe DG, Staka CM, Rakha EA, et al
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

VANKRUNKELSVEN P , Kellen E, Lousbergh D, Cloes E, et al
Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

CAO AY , Jin W, Shi PC, Di GH, et al
Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

FEHRINGER G , Boyd NF, Knight JA, Paterson AD, et al
Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

YANG R , Chen B, Hemminki K, Wappenschmidt B, et al
Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

TEBBIT CL , Zhai J, Untch BR, Ellis MJ, et al
Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

SHUHENDLER AJ , Cheung RY, Manias J, Connor A, et al
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

GUHA N , Kwan ML, Quesenberry CP Jr, Weltzien EK, et al
Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

CANFELL K , Banks E, Clements M, Kang YJ, et al
Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003.
Breast Cancer Res Treat. 2009.
PubMed Related articles

STRAVER ME , Glas AM, Hannemann J, Wesseling J, et al
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

SIGURDSON AJ , Bhatti P, Chang SC, Rajaraman P, et al
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

PALANCA SUELA S , Esteban Cardenosa E, Barragan Gonzalez E, de Juan Jimenez I, et al
CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

HINES SL , Mincey B, Dentchev T, Sloan JA, et al
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

BOSMAN JD , Yehiely F, Evans JR, Cryns VL, et al
Regulation of alphaB-crystallin gene expression by the transcription factor Ets1 in breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ROSA-ROSA JM , Pita G, Gonzalez-Neira A, Milne RL, et al
A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

LIU S , Chia SK, Mehl E, Leung S, et al
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

HUNT KK , Askew R, Cormier JN
Measuring lymphedema in patients with breast cancer: go with the flow?
Breast Cancer Res Treat. 2009.
PubMed Related articles

WANG Z , Xu Y, Tang J, Ma H, et al
A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ZHAO J , Chen G, Cao D, Li Y, et al
Expression of Gli1 correlates with the transition of breast cancer cells to estrogen-independent growth.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

SHIN HW , Noh DY, Lee ES, Nam SJ, et al
Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

BIJL MJ , van Schaik RH, Lammers LA, Hofman A, et al
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

RAMON Y CAJAL T , Altes A, Pare L, Del Rio E, et al
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

RAO NY , Hu Z, Li WF, Huang J, et al
Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients.
Breast Cancer Res Treat. 2009;113:467-77.
PubMed Related articles Abstract available

PEPELS MJ , Boomars KA, van Kimmenade R, Hupperets PS, et al
Life-threatening interstitial lung disease associated with trastuzumab: case report.
Breast Cancer Res Treat. 2009;113:609-12.
PubMed Related articles Abstract available

JANNUZZO MG , Di Salle E, Spinelli R, Pirotta N, et al
Estrogen suppression in premenopausal women following 8 weeks of treatment with exemestane and triptorelin versus triptorelin alone.
Breast Cancer Res Treat. 2009;113:491-9.
PubMed Related articles Abstract available

DONG K , Wang R, Wang X, Lin F, et al
Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Breast Cancer Res Treat. 2009;113:443-56.
PubMed Related articles Abstract available

January 2009

GREENLEE H , Kwan ML, Ergas IJ, Sherman KJ, et al
Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

BUCHHOLZ TA , Avritscher R, Yu TK
Identifying the "sentinel lymph nodes" for arm drainage as a strategy for minimizing the lymphedema risk after breast cancer therapy.
Breast Cancer Res Treat. 2009.
PubMed Related articles

MOLINA L , Matus CE, Astroza A, Pavicic F, et al
Stimulation of the bradykinin B(1) receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

MACKAY A , Tamber N, Fenwick K, Iravani M, et al
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

YANG R , Cheung MC, Hurley J, Byrne MM, et al
A comprehensive evaluation of outcomes for inflammatory breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

GHADIRIAN P , Narod S, Fafard E, Costa M, et al
Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

APOSTOLAKI S , Perraki M, Kallergi G, Kafousi M, et al
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Breast Cancer Res Treat. 2009.
PubMed Related articles

STICKELER E , Klar M, Watermann D, Geibel A, et al
Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

FAN L , Zheng Y, Yu KD, Liu GY, et al
Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ZHOU X , Cella D, Cameron D, Amonkar MM, et al
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

SVERRISDOTTIR A , Nystedt M, Johansson H, Fornander T, et al
Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

CHEVILLE AL , Das I, Srinivas S, Schuerman J, et al
A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

ROUZIER R , Coutant C, Lesieur B, Mazouni C, et al
Direct comparison of logistic regression and recursive partitioning to predict chemotherapy response of breast cancer based on clinical pathological variables.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

DU W , Mood D, Gadgeel S, Simon MS, et al
An educational video to increase clinical trials enrollment among breast cancer patients.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

DE BOCK GH , Putter H, Bonnema J, van der Hage JA, et al
The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

OSBORNE CR , Duncan A, Sedlacek S, Paul D, et al
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

PAGANI O , Price KN, Gelber RD, Castiglione-Gertsch M, et al
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

HAMMERICH-HILLE S , Bardout VJ, Hilsenbeck SG, Osborne CK, et al
Low SAFB levels are associated with worse outcome in breast cancer patients.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

GROSSONI VC , Todaro LB, Kazanietz MG, de Kier Joffe ED, et al
Opposite effects of protein kinase C beta1 (PKCbeta1) and PKCepsilon in the metastatic potential of a breast cancer murine model.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

LUX MP , Hartmann M, Jackisch C, Raab G, et al
Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

DUCHNOWSKA R , Dziadziuszko R, Czartoryska-Arlukowicz B, Radecka B, et al
Risk factors for brain relapse in HER2-positive metastatic breast cancer patients.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

BEWICK MA , Conlon MS, Lafrenie RM
Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles

FRANK DH , Kimler BF, Fabian CJ, Ranger-Moore J, et al
Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

TANG C , Chen N, Wu M, Yuan H, et al
Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

THOMAS RJ , Williams M, Glen J, Callam M, et al
Comparing the cost of adjuvant anastrozole with the benefits of managing less patients with relapsed breast cancer.
Breast Cancer Res Treat. 2009.
PubMed Related articles Abstract available

THOMASSEN M , Tan Q, Kruse TA
Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis.
Breast Cancer Res Treat. 2009;113:251-252.
PubMed Related articles

GOLFINOPOULOS V , Pentheroudakis G, Kamakari S, Metaxa-Mariatou V, et al
Donor-derived breast cancer in a bone marrow transplantation recipient.
Breast Cancer Res Treat. 2009;113:215.
PubMed Related articles

KROP IE , Winer EP
Ten years of HER2-directed therapy: still questions after all these years.
Breast Cancer Res Treat. 2009;113:207-9.
PubMed Related articles

LUINI A , Rososchansky J, Gatti G, Zurrida S, et al
The surgical margin status after breast-conserving surgery: discussion of an open issue.
Breast Cancer Res Treat. 2009;113:397-402.
PubMed Related articles Abstract available

MATHEW J , Agrawal A, Asgeirsson KS, Buhari SA, et al
Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.
Breast Cancer Res Treat. 2009;113:403-7.
PubMed Related articles Abstract available

SWAIN SM , Land SR, Ritter MW, Costantino JP, et al
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
Breast Cancer Res Treat. 2009;113:315-20.
PubMed Related articles Abstract available

SHIEN T , Shimizu C, Seki K, Shibata T, et al
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome.
Breast Cancer Res Treat. 2009;113:307-13.
PubMed Related articles Abstract available

KAPP JM , Ryerson AB, Coughlin SS, Thompson TD, et al
Racial and ethnic differences in mammography use among U.S. women younger than age 40.
Breast Cancer Res Treat. 2009;113:327-37.
PubMed Related articles Abstract available

VAN CALSTER B , Vanden Bempt I, Drijkoningen M, Pochet N, et al
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Breast Cancer Res Treat. 2009;113:181-7.
PubMed Related articles Abstract available

DIXON JM , Renshaw L, Macaskill EJ, Young O, et al
Increase in response rate by prolonged treatment with neoadjuvant letrozole.
Breast Cancer Res Treat. 2009;113:145-51.
PubMed Related articles Abstract available

MAASKANT AJ , van de Poll-Franse LV, Voogd AC, Coebergh JW, et al
Stage migration due to introduction of the sentinel node procedure: a population-based study.
Breast Cancer Res Treat. 2009;113:173-9.
PubMed Related articles Abstract available

SKELDING KA , Barry RD, Shafren DR
Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21.
Breast Cancer Res Treat. 2009;113:21-30.
PubMed Related articles Abstract available

ANDERSON WF , Luo S, Chatterjee N, Rosenberg PS, et al
Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.
Breast Cancer Res Treat. 2009;113:189-96.
PubMed Related articles Abstract available

MARTIN LJ , Greenberg CV, Kriukov V, Minkin S, et al
Effect of a low-fat, high-carbohydrate dietary intervention on change in mammographic density over menopause.
Breast Cancer Res Treat. 2009;113:163-72.
PubMed Related articles Abstract available

GREEN AR , Krivinskas S, Young P, Rakha EA, et al
Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.
Breast Cancer Res Treat. 2009;113:59-66.
PubMed Related articles Abstract available

HACHANA M , Trimeche M, Ziadi S, Amara K, et al
Evidence for a role of the Simian Virus 40 in human breast carcinomas.
Breast Cancer Res Treat. 2009;113:43-58.
PubMed Related articles Abstract available

December 2008

VO MN , Evans M, Leitzel K, Ali SM, et al
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

NESVOLD IL , Fossa SD, Naume B, Dahl AA, et al
Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MANSELL J , Monypenny IJ, Skene AI, Abram P, et al
Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

SHAYE A , Sahin A, Hao Q, Hunt K, et al
Cyclin E deregulation is an early event in the development of breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

DORJGOCHOO T , Gao YT, Chow WH, Shu XO, et al
Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS).
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

GLIGOROV J , Lotz JP
Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

CHLEBOWSKI RT
Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

ROY V , Perez EA
Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

LLOMBART-CUSSAC A
Improving decision-making in early breast cancer: who to treat and how?
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

JOHNATTY SE , Couch FJ, Fredericksen Z, Tarrell R, et al
No evidence that GATA3 rs570613 SNP modifies breast cancer risk.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

GAST MC , Schellens JH, Beijnen JH
Clinical proteomics in breast cancer: a review.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

YERUSHALMI R , Kennecke H, Woods R, Olivotto IA, et al
Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

WADHWA D , Fallah-Rad N, Grenier D, Krahn M, et al
Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

GYORFFY B , Schafer R
Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

STANTON AW , Modi S, Bennett Britton TM, Purushotham AD, et al
Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MANI A , Roda J, Young D, Caligiuri MA, et al
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

ROSATO R , Sacerdote C, Pagano E, Di Cuonzo D, et al
Appropriateness of early breast cancer management in relation to patient and hospital characteristics: a population based study in Northern Italy.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

OH EY , Wood PA, Yang X, Hrushesky WJ, et al
Discovery of candidate genes and pathways that may help explain fertility cycle stage dependent post-resection breast cancer outcome.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MORALES L , Neven P, Timmerman D, Wildiers H, et al
Prospective assessment of the endometrium in postmenopausal breast cancer patients treated with fulvestrant.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

AAPRO M
Editorial. Optimizing breast cancer patient care today and tomorrow: implications for clinicians.
Breast Cancer Res Treat. 2008;112 Suppl 1:1-3.
PubMed Related articles

BLACKWELL KL
Are all aromatase inhibitors alike?
Breast Cancer Res Treat. 2008;112 Suppl 1:35-43.
PubMed Related articles Abstract available

HARVELL DM , Richer JK, Singh M, Spoelstra N, et al
Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.
Breast Cancer Res Treat. 2008;112:489-501.
PubMed Related articles Abstract available

CALISKAN M , Gatti G, Sosnovskikh I, Rotmensz N, et al
Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Breast Cancer Res Treat. 2008;112:513-21.
PubMed Related articles Abstract available

PETIT JY , Gentilini O, Rotmensz N, Rey P, et al
Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution.
Breast Cancer Res Treat. 2008;112:545-9.
PubMed Related articles Abstract available

JENSEN KC , Turbin DA, Leung S, Miller MA, et al
New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up.
Breast Cancer Res Treat. 2008;112:453-9.
PubMed Related articles Abstract available

LV S , Niu Y, Wei L, Liu Q, et al
Chromosomal aberrations and genetic relations in benign, borderline and malignant phyllodes tumors of the breast: a comparative genomic hybridization study.
Breast Cancer Res Treat. 2008;112:411-8.
PubMed Related articles Abstract available

CHOI DH , Cho DY, Lee MH, Park HS, et al
The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation.
Breast Cancer Res Treat. 2008;112:569-73.
PubMed Related articles Abstract available

QADIR MA , Kwok B, Dragowska WH, To KH, et al
Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization.
Breast Cancer Res Treat. 2008;112:389-403.
PubMed Related articles Abstract available

IHNEN M , Muller V, Wirtz RM, Schroder C, et al
Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
Breast Cancer Res Treat. 2008;112:419-27.
PubMed Related articles Abstract available

KLAR M , Jochmann A, Foeldi M, Stumpf M, et al
The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population.
Breast Cancer Res Treat. 2008;112:523-31.
PubMed Related articles Abstract available

BRAUN M , Flucke U, Debald M, Walgenbach-Bruenagel G, et al
Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
Breast Cancer Res Treat. 2008;112:503-11.
PubMed Related articles Abstract available

NAKAYAMA S , Miyoshi Y, Ishihara H, Noguchi S, et al
Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis.
Breast Cancer Res Treat. 2008;112:405-10.
PubMed Related articles Abstract available

November 2008

CHANG ET , Milne RL, Phillips KA, Figueiredo JC, et al
Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

LEVANGIE PK , Drouin J
Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MAURIAC L , Romieu G, Bines J
Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases: data from the EFECT trial.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

SERRANO-FERNANDEZ P , Debniak T, Gorski B, Bogdanova N, et al
Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

FALANDRY C , Debled M, Bachelot T, Delozier T, et al
Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

JEZEQUEL P , Campone M, Roche H, Gouraud W, et al
A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

AMARAL S , Schroth W, Kugler S, Fritz P, et al
The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MCINERNEY N , Colleran G, Rowan A, Walther A, et al
Low penetrance breast cancer predisposition SNPs are site specific.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

SHAMLEY D , Srinaganathan R, Oskrochi R, Lascurain-Aguirrebena I, et al
Three-dimensional scapulothoracic motion following treatment for breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

LEE MS , Kim KH, Choi SM, Ernst E, et al
Acupuncture for treating hot flashes in breast cancer patients: a systematic review.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

LAI L , Yuan L, Cheng Q, Dong C, et al
Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

ZHAO YS , Zhu S, Li XW, Wang F, et al
Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

CRONIN KA , Ravdin PM, Edwards BK
Sustained lower rates of breast cancer in the United States.
Breast Cancer Res Treat. 2008.
PubMed Related articles

BUTLER LM , Gold EB, Greendale GA, Crandall CJ, et al
Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN).
Breast Cancer Res Treat. 2008;112:165-74.
PubMed Related articles Abstract available

VERHEUS M , McKay JD, Kaaks R, Canzian F, et al
Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density.
Breast Cancer Res Treat. 2008;112:109-22.
PubMed Related articles Abstract available

KO E , Han W, Lee JW, Cho J, et al
Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy.
Breast Cancer Res Treat. 2008;112:189-95.
PubMed Related articles Abstract available

ESTEBAN CARDENOSA E , Bolufer Gilabert P, Palanca Suela S, Oltra Soler S, et al
Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain.
Breast Cancer Res Treat. 2008;112:69-73.
PubMed Related articles Abstract available

PALANCA SUELA S , Esteban Cardenosa E, Barragan Gonzalez E, Oltra Soler S, et al
Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Breast Cancer Res Treat. 2008;112:63-7.
PubMed Related articles Abstract available

MASKARINEC G , Urano Y, Gill J, Kolonel LN, et al
Nonsteroidal anti-inflammatory drugs (NSAIDs) and mammographic density.
Breast Cancer Res Treat. 2008;112:133-9.
PubMed Related articles Abstract available

MIRAMAR MD , Calvo MT, Rodriguez A, Anton A, et al
Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1.
Breast Cancer Res Treat. 2008;112:353-8.
PubMed Related articles Abstract available

KIM H , Chung H, Kim HJ, Lee JY, et al
Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
Breast Cancer Res Treat. 2008;112:287-96.
PubMed Related articles Abstract available

ROSLIND A , Knoop AS, Jensen MB, Johansen JS, et al
YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.
Breast Cancer Res Treat. 2008;112:275-85.
PubMed Related articles Abstract available

PATIL DB , Lankes HA, Nayar R, Masood S, et al
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women.
Breast Cancer Res Treat. 2008;112:327-33.
PubMed Related articles Abstract available

CYBULSKI C , Wokolorczyk D, Gliniewicz B, Sikorski A, et al
A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population.
Breast Cancer Res Treat. 2008;112:367-8.
PubMed Related articles

SCHULZE EB , Hedley BD, Goodale D, Postenka CO, et al
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Breast Cancer Res Treat. 2008;112:243-54.
PubMed Related articles Abstract available

XU H , Washington S, Verderame MF, Manni A, et al
Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Breast Cancer Res Treat. 2008;112:255-61.
PubMed Related articles Abstract available

JAWOROWSKA E , Serrano-Fernandez P, Tarnowska C, Lubinski J, et al
Familial association of laryngeal, lung, stomach and early-onset breast cancer.
Breast Cancer Res Treat. 2008;112:359-61.
PubMed Related articles Abstract available

WALKER LC , Waddell N, Ten Haaf A, Grimmond S, et al
Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Breast Cancer Res Treat. 2008;112:229-36.
PubMed Related articles Abstract available

GORRINGE KL , Choong DY, Lindeman GJ, Visvader JE, et al
Breast cancer risk and the BRCA1 interacting protein CTIP.
Breast Cancer Res Treat. 2008;112:351-2.
PubMed Related articles Abstract available

SEYMOUR IJ , Casadei S, Zampiga V, Rosato S, et al
Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.
Breast Cancer Res Treat. 2008;112:343-9.
PubMed Related articles Abstract available

TAUCHER S , Steger GG, Jakesz R, Tausch C, et al
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
Breast Cancer Res Treat. 2008;112:309-16.
PubMed Related articles Abstract available

CLAR H , Renner W, Krippl P, Leithner A, et al
The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer.
Breast Cancer Res Treat. 2008;112:363-5.
PubMed Related articles

GRAU AM , Wen W, Ramroopsingh DS, Gao YT, et al
Circulating transforming growth factor-beta-1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study.
Breast Cancer Res Treat. 2008;112:335-41.
PubMed Related articles Abstract available

ZHANG H , Liu G, Dziubinski M, Yang Z, et al
Comprehensive analysis of oncogenic effects of PIK3CA mutations in human mammary epithelial cells.
Breast Cancer Res Treat. 2008;112:217-27.
PubMed Related articles Abstract available

October 2008

WATANABE M , Miyajima N, Igarashi M, Endo Y, et al
Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

PAGANI O , Gelber S, Simoncini E, Castiglione-Gertsch M, et al
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

DEL BARCO S , Colomer R, Calvo L, Tusquets I, et al
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

COLLEONI M , Bagnardi V, Rotmensz N, Gelber RD, et al
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

QIAN B , Katsaros D, Lu L, Preti M, et al
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

CLUZE C , Colonna M, Remontet L, Poncet F, et al
Analysis of the effect of age on the prognosis of breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

WAYNE SJ , Neuhouser ML, Koprowski C, Ulrich CM, et al
Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

SMITH MJ , Gill PG, Wetzig N, Sourjina T, et al
Comparing patients' and clinicians' assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial).
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

SPECHT K , Harbeck N, Smida J, Annecke K, et al
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

CASTELLON S , Ganz PA
Neuropsychological studies in breast cancer: in search of chemobrain.
Breast Cancer Res Treat. 2008.
PubMed Related articles

BROWN SB , Morrison DS, Cooke TG
Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

AHN E , Cho J, Shin DW, Park BW, et al
Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

LI Z , Carrier L, Belame A, Thiyagarajah A, et al
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

GOLDBLATT EM , Erickson PA, Gentry ER, Gryaznov SM, et al
Lipid-conjugated telomerase template antagonists sensitize resistant HER2-positive breast cancer cells to trastuzumab.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

TJENSVOLL K , Gilje B, Oltedal S, Shammas VF, et al
A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

TAN AR , Alexe G, Reiss M
Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

GREENLEE H , Hershman DL, Jacobson JS
Use of antioxidant supplements during breast cancer treatment: a comprehensive review.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

HERVIK J , Mjaland O
Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

WORSHAM MJ , Raju U, Lu M, Kapke A, et al
Risk factors for breast cancer from benign breast disease in a diverse population.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

DIGNAM JJ , Dukic V, Anderson SJ, Mamounas EP, et al
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

YARDEN RI , Friedman E, Metsuyanim S, Olender T, et al
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Breast Cancer Res Treat. 2008;111:497-504.
PubMed Related articles Abstract available

DI SAVERIO S , Gutierrez J, Avisar E
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Breast Cancer Res Treat. 2008;111:541-7.
PubMed Related articles Abstract available

YANG WT , Dryden M, Broglio K, Gilcrease M, et al
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women.
Breast Cancer Res Treat. 2008;111:405-10.
PubMed Related articles Abstract available

BATES GJ , Fox SB, Han C, Launchbury R, et al
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas.
Breast Cancer Res Treat. 2008;111:453-9.
PubMed Related articles Abstract available

SIDONI A , Cartaginese F, Colozza M, Gori S, et al
ERCC1 expression in triple negative breast carcinoma: the paradox revisited.
Breast Cancer Res Treat. 2008;111:569-70.
PubMed Related articles

INNOS K , Horn-Ross PL
Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
Breast Cancer Res Treat. 2008;111:531-40.
PubMed Related articles Abstract available

PATANI N , Mokbel K
Oncological and aesthetic considerations of skin-sparing mastectomy.
Breast Cancer Res Treat. 2008;111:391-403.
PubMed Related articles Abstract available

September 2008

WITTHAUER J , Schlereth B, Brischwein K, Winter H, et al
Lysis of cancer cells by autologous T cells in breast cancer pleural effusates treated with anti-EpCAM BiTE antibody MT110.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

BUENO-DE-MESQUITA JM , Linn SC, Keijzer R, Wesseling J, et al
Validation of 70-gene prognosis signature in node-negative breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

OTTINI L , Rizzolo P, Zanna I, Falchetti M, et al
BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

LU C , Dong J, Ma H, Jin G, et al
CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MORIAI R , Tsuji N, Moriai M, Kobayashi D, et al
Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

ZHAO L , Wang L, Jin F, Ma W, et al
Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

TEUGELS E , De Greve J
About the c.156_157insAlu BRCA2 breast cancer predisposing mutation.
Breast Cancer Res Treat. 2008.
PubMed Related articles

BOGDANOVA N , Cybulski C, Bermisheva M, Datsyuk I, et al
A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

RAO NY , Hu Z, Yu JM, Li WF, et al
Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

SENGUPTA S , Schiff R, Katzenellenbogen BS
Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

BECKER S , Becker-Pergola G, Banys M, Krawczyk N, et al
Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

WANG R , Wang X, Li B, Lin F, et al
Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

GENNARI A , De Tursi M, Carella C, Ricevuto E, et al
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

KEAM B , Im SA, Kim HJ, Oh DY, et al
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

BIGELOW RL , Williams BJ, Carroll JL, Daves LK, et al
TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

GOSS PE
Extending the benefits of adjuvant therapy in early HR+ breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

DUFFY CM , Assaf A, Cyr M, Burkholder G, et al
Alcohol and folate intake and breast cancer risk in the WHI Observational Study.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

BREWER NT , Edwards AS, O'Neill SC, Tzeng JP, et al
When genomic and standard test results diverge: implications for breast cancer patients' preference for chemotherapy.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

CARDOSO MJ , Cardoso JS, Wild T, Krois W, et al
Comparing two objective methods for the aesthetic evaluation of breast cancer conservative treatment.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

IWASAKI M , Hamada GS, Nishimoto IN, Netto MM, et al
Dietary isoflavone intake and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

EROGLU A , Cam R, Egin Y, Akar N, et al
Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles

WEI M , Xu J, Dignam J, Nanda R, et al
Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
Breast Cancer Res Treat. 2008;111:113-20.
PubMed Related articles Abstract available

RAKHA EA , El-Sayed ME, Menon S, Green AR, et al
Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast.
Breast Cancer Res Treat. 2008;111:121-7.
PubMed Related articles Abstract available

PATANI N , Cutuli B, Mokbel K
Current management of DCIS: a review.
Breast Cancer Res Treat. 2008;111:1-10.
PubMed Related articles Abstract available

KNOWLDEN JM , Jones HE, Barrow D, Gee JM, et al
Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Breast Cancer Res Treat. 2008;111:79-91.
PubMed Related articles Abstract available

PRYZBYLKOWSKI P , Obajimi O, Keen JC
Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR.
Breast Cancer Res Treat. 2008;111:15-25.
PubMed Related articles Abstract available

DALBERG K , Hellborg H, Warnberg F
Paget's disease of the nipple in a population based cohort.
Breast Cancer Res Treat. 2008;111:313-9.
PubMed Related articles Abstract available

BRANCATO B , Houssami N, Francesca D, Bianchi S, et al
Does computer-aided detection (CAD) contribute to the performance of digital mammography in a self-referred population?
Breast Cancer Res Treat. 2008;111:373-6.
PubMed Related articles Abstract available

SUBRAMANIAN A , Salhab M, Mokbel K
Oestrogen producing enzymes and mammary carcinogenesis: a review.
Breast Cancer Res Treat. 2008;111:191-202.
PubMed Related articles Abstract available

CORADINI D , Gariboldi M, Fedeli M, Pierotti MA, et al
Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen.
Breast Cancer Res Treat. 2008;111:389-90.
PubMed Related articles

August 2008

WASIELEWSKI M , den Bakker MA, van den Ouweland A, Meijer-van Gelder ME, et al
CHEK2 1100delC and male breast cancer in the Netherlands.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MILANO MT , Zhang H, Metcalfe SK, Muhs AG, et al
Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MANSEL RE , Goyal A, Douglas-Jones A, Woods V, et al
Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearchtrade mark BLN Assay in the operating room: results of the Cardiff study.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

PECCATORI FA , Azim HA Jr, Scarfone G, Gadducci A, et al
Weekly epirubicin in the treatment of gestational breast cancer (GBC).
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

CARPENTER CL , Ganz PA, Bernstein L
Complementary and alternative therapies among very long-term breast cancer survivors.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

LAUNAY-VACHER V , Gligorov J, Le Tourneau C, Janus N, et al
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

NEUHAUSEN SL , Ozcelik H, Southey MC, John EM, et al
BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

NOVAK DJ , Sabbaghian N, Maillet P, Chappuis PO, et al
Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

FLEMMING J , Madarnas Y, Franek JA
Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: a systematic review.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

ZHOU Q , Shaw PG, Davidson NE
Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MAX W , Sung HY, Stark B
The economic burden of breast cancer in California.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

TEWES M , Aktas B, Welt A, Mueller S, et al
Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

ABU-KHALAF MM , Harris L
The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles

BUIJS C , Mom CH, Willemse PH, Marike Boezen H, et al
Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

WANG C , Baumgartner RN, Yang D, Slattery ML, et al
No evidence of association between breast cancer risk and dietary carotenoids, retinols, vitamin C and tocopherols in Southwestern Hispanic and non-Hispanic White women.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

TURBIN DA , Leung S, Cheang MC, Kennecke HA, et al
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
Breast Cancer Res Treat. 2008;110:417-26.
PubMed Related articles Abstract available

MARTINEZ V , Kennedy S, Doolan P, Gammell P, et al
Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue.
Breast Cancer Res Treat. 2008;110:521-30.
PubMed Related articles Abstract available

TOI M , Nakamura S, Kuroi K, Iwata H, et al
Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival.
Breast Cancer Res Treat. 2008;110:531-9.
PubMed Related articles Abstract available

July 2008

BELOVA L , Delgado B, Kocherginsky M, Melhem A, et al
Glucocorticoid receptor expression in breast cancer associates with older patient age.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

PENTHEROUDAKIS G , Kalogeras KT, Wirtz RM, Grimani I, et al
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

BAAK JP , Gudlaugsson E, Skaland I, Guo LH, et al
Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

MOOK S , Schmidt MK, Viale G, Pruneri G, et al
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

BARTSCH R , Mlineritsch B, Gnant M, Niernberger T, et al
The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

YANG X , Wood PA, Oh EY, Du-Quiton J, et al
Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

BYRSKI T , Huzarski T, Dent R, Gronwald J, et al
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients.
Breast Cancer Res Treat. 2008.
PubMed Related articles Abstract available

RABI T , Bishayee A
Terpenoids and breast cancer chemoprevention.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

BROUCKAERT O , Pintens S, Van Belle V, Van Huffel S, et al
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

QUESNEL C , Savard J, Ivers H
Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

JANSEN MP , Ruigrok-Ritstier K, Dorssers LC, van Staveren IL, et al
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

ZHANG L , Gu L, Qian B, Hao X, et al
Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

ZAUDERER M , Patil S, Hurria A
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

LAWRENCE G , Wallis M, Allgood P, Nagtegaal ID, et al
Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

AUER D , Reimer D, Porto V, Fleischer M, et al
Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

ANDERSON BO , Bleiweiss IJ
Is PCR testing of sentinel lymph nodes ready for clinical application in breast cancer?
Breast Cancer Res Treat. 2008;.
PubMed Related articles

SANDHU MK , Brezden-Masley C, Lipscombe LL, Zagorski B, et al
Autoimmune hypothyroidism and breast cancer in the elderly.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

ECK SM , Hoopes PJ, Petrella BL, Coon CI, et al
Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

KORKMAZ A , Sanchez-Barcelo EJ, Tan DX, Reiter RJ, et al
Role of melatonin in the epigenetic regulation of breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

CALABRO A , Beissbarth T, Kuner R, Stojanov M, et al
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

RAO MV , Shayne M
Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles

JONES RL , Salter J, A'hern R, Nerurkar A, et al
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

CASEY TM , Eneman J, Crocker A, White J, et al
Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study.
Breast Cancer Res Treat. 2008;110:39-49.
PubMed Related articles Abstract available

June 2008

GAPSKA P , Scott RJ, Serrano-Fernandez P, Huzarski T, et al
Vitamin D receptor variants and breast cancer risk in the Polish population.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

COTICCHIA CM , Revankar CM, Deb TB, Dickson RB, et al
Calmodulin modulates Akt activity in human breast cancer cell lines.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

TURASHVILI G , McKinney S, Martin L, Gelmon KA, et al
Columnar cell lesions, mammographic density and breast cancer risk.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

BAFFORD AC , Burstein HJ, Barkley CR, Smith BL, et al
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

SAXENA A , Dhillon VS, Raish M, Asim M, et al
Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

DIGNAM JJ , Dukic VM
Comments on: Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Time-varying pattern of recurrence risk for Chinese breast cancer patients.
Breast Cancer Res Treat. 2008;.
PubMed Related articles

ZHANG X , Harrington N, Moraes RC, Wu MF, et al
Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo).
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

JOURNE F , Durbecq V, Chaboteaux C, Rouas G, et al
Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

YIN WJ , Lu JS, Di GH, Lin YP, et al
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

LOIZIDOU MA , Michael T, Neuhausen SL, Newbold RF, et al
DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

HAN J , Haiman C, Niu T, Guo Q, et al
Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

MAJED B , Moreau T, Asselain B
Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

FALLOWFIELD LJ
Treatment decision-making in breast cancer: the patient-doctor relationship.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

PARTRIDGE AH , Wolff AC, Marcom PK, Kaufman PA, et al
The impact of sharing results of a randomized breast cancer clinical trial with study participants.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

SPURDLE AB , Deans AJ, Duffy D, Goldgar DE, et al
No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

DENT R , Hanna WM, Trudeau M, Rawlinson E, et al
Pattern of metastatic spread in triple-negative breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

REBBECK TR , Antoniou AC, Llopis TC, Nevanlinna H, et al
No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

POTTER SM , Dwyer RM, Curran CE, Hennessy E, et al
Systemic chemokine levels in breast cancer patients and their relationship with circulating menstrual hormones.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

LANZINO M , Garofalo C, Morelli C, Le Pera M, et al
Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

SIKORA MJ , Cordero KE, Larios JM, Johnson MD, et al
The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

HARIGOPAL M , Heymann J, Ghosh S, Anagnostou V, et al
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

XU X , Gammon MD, Zhang Y, Bestor TH, et al
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

JUSTENHOVEN C , Hamann U, Pierl CB, Baisch C, et al
CYP2C19*17 is associated with decreased breast cancer risk.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

DI SAVERIO S , Catena F, Santini D, Ansaloni L, et al
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Breast Cancer Res Treat. 2008;109:405-16.
PubMed Related articles Abstract available

KONECNY M , Zavodna K, Vranova V, Vizvaryova M, et al
Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques.
Breast Cancer Res Treat. 2008;109:581-3.
PubMed Related articles

SHIROIWA T , Fukuda T, Shimozuma K, Ohashi Y, et al
The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data.
Breast Cancer Res Treat. 2008;109:559-66.
PubMed Related articles Abstract available

SIRIWARDHANA N , Choudhary S, Wang HC
Precancerous model of human breast epithelial cells induced by NNK for prevention.
Breast Cancer Res Treat. 2008;109:427-41.
PubMed Related articles Abstract available

May 2008

YANG Q , Moran MS, Haffty BG
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

JACOBI CE , de Bock GH, Siegerink B, van Asperen CJ, et al
Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

CHEN W , Pan K, Ouyang T, Li J, et al
BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

HAN HS , Ro J, Lee KS, Nam BH, et al
Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

ZHOU J , Zhang H, Gu P, Margolick JB, et al
Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

PAL SK , Blazer K, Weitzel J, Somlo G, et al
An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

BEYER SJ , Jimenez RE, Shapiro CL, Cho JY, et al
Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

CAM R , Eroglu A, Egin Y, Akar N, et al
Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles

DICKLER MN , Cobleigh MA, Miller KD, Klein PM, et al
Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

HISCOX S , Jordan NJ, Smith C, James M, et al
Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

VAN NES JG , Putter H, Julien JP, Tubiana-Hulin M, et al
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

FOUNTZILAS G , Dafni U, Dimopoulos MA, Koutras A, et al
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer : A Hellenic Cooperative Oncology Group study.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

CAO AY , Huang J, Hu Z, Li WF, et al
Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

GINSBURG O , Ghadirian P, Lubinski J, Cybulski C, et al
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

JOHNATTY SE , Beesley J, Chen X, Hopper JL, et al
The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

MU L , Katsaros D, Wiley A, Lu L, et al
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

SAADAT M , Ansari-Lari M
Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

SPEIRS V , Shaaban AM
The rising incidence of male breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles

AMAR S , Roy V, Perez EA
Treatment of metastatic breast cancer: looking towards the future.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

CHIRIVELLA I , Bermejo B, Insa A, Perez-Fidalgo A, et al
Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

TAO MH , Shields PG, Nie J, Millen A, et al
DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

KIBRIYA MG , Jasmine F, Argos M, Andrulis IL, et al
A pilot genome-wide association study of early-onset breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

BEINER ME , Zhang WW, Zhang S, Gallinger S, et al
Mutations of the MYH gene do not substantially contribute to the risk of breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

ZOGRAFOS GC , Zagouri F, Sergentanis TN, Nonni A, et al
Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study.
Breast Cancer Res Treat. 2008;109:397-402.
PubMed Related articles Abstract available

TSE GM , Tan PH, Lui PC, Putti TC, et al
Spindle cell lesions of the breast--the pathologic differential diagnosis.
Breast Cancer Res Treat. 2008;109:199-207.
PubMed Related articles Abstract available

KILGOUR RD , Jones DH, Keyserlingk JR
Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study.
Breast Cancer Res Treat. 2008;109:285-95.
PubMed Related articles Abstract available

UEMATSU T , Kasami M
Core wash cytology of breast lesions by ultrasonographically guided core needle biopsy.
Breast Cancer Res Treat. 2008;109:251-3.
PubMed Related articles Abstract available

BERESFORD MJ , Stott D, Makris A
Assessment of clinical response after two cycles of primary chemotherapy in breast cancer.
Breast Cancer Res Treat. 2008;109:337-42.
PubMed Related articles Abstract available

DIZDAR O , Bulut N, Altundag K
Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.
Breast Cancer Res Treat. 2008;109:403.
PubMed Related articles

SINGH-RANGER G , Salhab M, Mokbel K
The role of cyclooxygenase-2 in breast cancer: review.
Breast Cancer Res Treat. 2008;109:189-98.
PubMed Related articles Abstract available

DOOLAN P , Clynes M, Kennedy S, Mehta JP, et al
Prevalence and prognostic and predictive relevance of PRAME in breast cancer.
Breast Cancer Res Treat. 2008;109:359-65.
PubMed Related articles Abstract available

VANDERLAAG K , Su Y, Frankel AE, Grage H, et al
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Breast Cancer Res Treat. 2008;109:273-83.
PubMed Related articles Abstract available

CASSIER PA , Chabaud S, Trillet-Lenoir V, Peaud PY, et al
A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study.
Breast Cancer Res Treat. 2008;109:343-50.
PubMed Related articles Abstract available

DE CREMOUX P , Thioux M, Lebigot I, Sigal-Zafrani B, et al
No evidence of human papillomavirus DNA sequences in invasive breast carcinoma.
Breast Cancer Res Treat. 2008;109:55-8.
PubMed Related articles Abstract available

SAKODA LC , Blackston CR, Xue K, Doherty JA, et al
Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women.
Breast Cancer Res Treat. 2008;109:143-55.
PubMed Related articles Abstract available

CHEEMA B , Gaul CA, Lane K, Fiatarone Singh MA, et al
Progressive resistance training in breast cancer: a systematic review of clinical trials.
Breast Cancer Res Treat. 2008;109:9-26.
PubMed Related articles Abstract available

SALHAB M , Jiang WG, Newbold RF, Mokbel K, et al
The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome.
Breast Cancer Res Treat. 2008;109:35-46.
PubMed Related articles Abstract available

MA H , Hill CK, Bernstein L, Ursin G, et al
Low-dose medical radiation exposure and breast cancer risk in women under age 50 years overall and by estrogen and progesterone receptor status: results from a case-control and a case-case comparison.
Breast Cancer Res Treat. 2008;109:77-90.
PubMed Related articles Abstract available

KNIGHT JA , Lesosky M, Blackmore KM, Voigt LF, et al
Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study.
Breast Cancer Res Treat. 2008;109:157-64.
PubMed Related articles Abstract available

LEI H , Hemminki K, Johansson R, Altieri A, et al
PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer.
Breast Cancer Res Treat. 2008;109:165-75.
PubMed Related articles Abstract available

COSTA S , Pinto D, Pereira D, Rodrigues H, et al
XRCC1 Arg399Gln and RAD51 5'UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients.
Breast Cancer Res Treat. 2008;109:183-5.
PubMed Related articles

FERRETTI G , Papaldo P
Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Breast Cancer Res Treat. 2008;109:187-8.
PubMed Related articles

SLATTERY ML , Curtin K, Giuliano AR, Sweeney C, et al
Active and passive smoking, IL6, ESR1, and breast cancer risk.
Breast Cancer Res Treat. 2008;109:101-11.
PubMed Related articles Abstract available

JOHNATTY SE , Spurdle AB, Beesley J, Chen X, et al
Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
Breast Cancer Res Treat. 2008;109:91-9.
PubMed Related articles Abstract available

NEVEN P , Paridaens R, Pelgrims G, Martens M, et al
Fulvestrant (Faslodex) in advanced breast cancer: clinical experience from a Belgian cooperative study.
Breast Cancer Res Treat. 2008;109:59-65.
PubMed Related articles Abstract available

MORENO H JR
Genetic polymorphisms and haplotypes of eNOS in breast cancer.
Breast Cancer Res Treat. 2008;109:181-2.
PubMed Related articles

SAMIMI G , Colditz GA, Baer HJ, Tamimi RM, et al
Measures of energy balance and mammographic density in the Nurses' Health Study.
Breast Cancer Res Treat. 2008;109:113-22.
PubMed Related articles Abstract available

BYRD KN , Huey B, Roydasgupta R, Fridlyand J, et al
FBXW7 and DNA copy number instability.
Breast Cancer Res Treat. 2008;109:47-54.
PubMed Related articles Abstract available

MILLIKAN RC , Newman B, Tse CK, Moorman PG, et al
Epidemiology of basal-like breast cancer.
Breast Cancer Res Treat. 2008;109:123-39.
PubMed Related articles Abstract available

JERONIMO C , Monteiro P, Henrique R, Dinis-Ribeiro M, et al
Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
Breast Cancer Res Treat. 2008;109:27-34.
PubMed Related articles Abstract available

HAMMET F , George J, Tesoriero AA, Jenkins MA, et al
Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?
Breast Cancer Res Treat. 2008;109:177-9.
PubMed Related articles

April 2008

CAO AY , Huang J, Hu Z, Li WF, et al
The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

AU HJ , Golmohammadi K, Younis T, Verma S, et al
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effects.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

PEREZ EA
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

TAO W , Wang C, Han R, Jiang H, et al
HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

STAMBOLIC V , Woodgett JR, Fantus IG, Pritchard KI, et al
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Breast Cancer Res Treat. 2008;.
PubMed Related articles

GOODWIN PJ , Ennis M, Bahl M, Fantus IG, et al
High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

SCHEGERIN M , Tosteson AN, Kaufman PA, Paulsen KD, et al
Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

WELSH ML , Buist DS, Aiello Bowles EJ, Anderson ML, et al
Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

COSTANTINO L , Catalano MG, Frairia R, Carmazzi CM, et al
Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

BRAMWELL VH , Doig GS, Tuck AB, Wilson SM, et al
Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

LEE SG , Jee YG, Chung HC, Kim SB, et al
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC).
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

YUVARAJ S , Premkumar VG, Shanthi P, Vijayasarathy K, et al
Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

PATANI N , Mokbel K
The clinical significance of sentinel lymph node micrometastasis in breast cancer.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

YIN W , Di G, Zhou L, Lu J, et al
Time-varying pattern of recurrence risk for Chinese breast cancer patients.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

HADAD SM , Appleyard V, Thompson AM
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.
Breast Cancer Res Treat. 2008;.
PubMed Related articles

LU WL , Jansen L, Post WJ, Bonnema J, et al
Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

ZHANG H , Sachdev D, Wang C, Hubel A, et al
Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

30th Annual San Antonio Breast Cancer Symposium Late Breaking Abstracts.
Breast Cancer Res Treat. 2008;.
PubMed Related articles

HENSLEY ALFORD S , Schwartz K, Soliman A, Johnson CC, et al
Breast cancer characteristics at diagnosis and survival among Arab-American women compared to European- and African-American women.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

FROGNE T , Benjaminsen RV, Sonne-Hansen K, Sorensen BS, et al
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

KOHAAR I , Tiwari P, Kumar R, Nasare V, et al
Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

LU W , Cui Y, Chen X, Zheng Y, et al
Changes in quality of life among breast cancer patients three years post-diagnosis.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

JONES RJ , Young O, Renshaw L, Jacobs V, et al
Src inhibitors in early breast cancer: a methodology, feasibility and variability study.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

MARQUES AR , Teixeira E, Diamond J, Correia H, et al
Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

YEE KO , Connolly CM, Duquette M, Kazerounian S, et al
The effect of thrombospondin-1 on breast cancer metastasis.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

CARRAWAY HE , Wang S, Blackford A, Guo M, et al
Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

PIERCE BL , Neuhouser ML, Wener MH, Bernstein L, et al
Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

LACROIX M
Poor usage of HUGO standard gene nomenclature in breast cancer studies.
Breast Cancer Res Treat. 2008;.
PubMed Related articles

NKHATA KJ , Ray A, Dogan S, Grande JP, et al
Mammary tumor development from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements.
Breast Cancer Res Treat. 2008;.
PubMed Related articles Abstract available

STUTE P , Gotte M, Kiesel L
Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
Breast Cancer Res Treat. 2008;108:363-74.
PubMed Related articles Abstract available

March 2008

MCTIERNAN A , Wu L, Barnabei VM, Chen C, et al
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women.
Breast Cancer Res Treat. 2008;108:217-31.
PubMed Related articles Abstract available

CHAVEZ-MACGREGOR M , van Gils CH, van der Schouw YT, Monninkhof E, et al
Lifetime cumulative number of menstrual cycles and serum sex hormone levels in postmenopausal women.
Breast Cancer Res Treat. 2008;108:101-12.
PubMed Related articles Abstract available Free Full Text

GAO J , Warren R, Warren-Forward H, Forbes JF, et al
Reproducibility of visual assessment on mammographic density.
Breast Cancer Res Treat. 2008;108:121-7.
PubMed Related articles Abstract available

STOFF-KHALILI MA , Rivera AA, Nedeljkovic-Kurepa A, DeBenedetti A, et al
Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.
Breast Cancer Res Treat. 2008;108:43-55.
PubMed Related articles Abstract available

BYRSKI T , Gronwald J, Huzarski T, Grzybowska E, et al
Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers.
Breast Cancer Res Treat. 2008;108:289-96.
PubMed Related articles Abstract available

LIU GY , Lu JS, Shen KW, Wu J, et al
Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge.
Breast Cancer Res Treat. 2008;108:271-7.
PubMed Related articles Abstract available

LEFF DR , Warren OJ, Enfield LC, Gibson A, et al
Diffuse optical imaging of the healthy and diseased breast: a systematic review.
Breast Cancer Res Treat. 2008;108:9-22.
PubMed Related articles Abstract available

OKARVI SM
Evaluation of radiolabeled bombesin analogs in animals.
Breast Cancer Res Treat. 2008;108:151.
PubMed Related articles

February 2008

GUTIERREZ-ENRIQUEZ S , Balmana J, Baiget M, Diez O, et al
Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: a worthwhile strategy for its clinical applicability in 1100delC low-frequency populations?
Breast Cancer Res Treat. 2008;107:455-7.
PubMed Related articles

MANFRIN E , Remo A, Falsirollo F, Reghellin D, et al
Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases.
Breast Cancer Res Treat. 2008;107:371-7.
PubMed Related articles Abstract available

GUSEVA NV , Rokhlin OW, Taghiyev AF, Cohen MB, et al
Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
Breast Cancer Res Treat. 2008;107:349-57.
PubMed Related articles Abstract available

KONSTANTOPOULOU I , Rampias T, Ladopoulou A, Koutsodontis G, et al
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
Breast Cancer Res Treat. 2008;107:431-41.
PubMed Related articles Abstract available

STARK A , Kapke A, Schultz D, Brown R, et al
Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women.
Breast Cancer Res Treat. 2008;107:405-14.
PubMed Related articles Abstract available

January 2008

RASHID MU , Torres D, Zaidi A, Rasheed F, et al
No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.
Breast Cancer Res Treat. 2008;107:155-6.
PubMed Related articles

NAIK RP , Jin D, Chuang E, Gold EG, et al
Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer.
Breast Cancer Res Treat. 2008;107:133-8.
PubMed Related articles Abstract available

YU CP , Yu JC, Sun CA, Tzao C, et al
Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Breast Cancer Res Treat. 2008;107:95-102.
PubMed Related articles Abstract available

TAKEI H , Suemasu K, Inoue K, Saito T, et al
Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).
Breast Cancer Res Treat. 2008;107:87-94.
PubMed Related articles Abstract available

KHOSHNOUD MR , Fornander T, Johansson H, Rutqvist LE, et al
Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
Breast Cancer Res Treat. 2008;107:71-8.
PubMed Related articles Abstract available

BUCK MB , Coller JK, Murdter TE, Eichelbaum M, et al
TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.
Breast Cancer Res Treat. 2008;107:15-24.
PubMed Related articles Abstract available

MANN RM , Hoogeveen YL, Blickman JG, Boetes C, et al
MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature.
Breast Cancer Res Treat. 2008;107:1-14.
PubMed Related articles Abstract available

CELLA D , Fallowfield LJ
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
Breast Cancer Res Treat. 2008;107:167-80.
PubMed Related articles Abstract available

SUBRAMANIAN A , Sharma A, Mokbel K
Insulin-like growth factor binding proteins and breast cancer.
Breast Cancer Res Treat. 2008;107:181-94.
PubMed Related articles

JEREVALL PL , Brommesson S, Strand C, Gruvberger-Saal S, et al
Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.
Breast Cancer Res Treat. 2008;107:225-34.
PubMed Related articles Abstract available

LEUNEN K , Drijkoningen M, Neven P, Christiaens MR, et al
Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us?
Breast Cancer Res Treat. 2008;107:79-86.
PubMed Related articles Abstract available

KALLIANPUR AR , Lee SA, Gao YT, Lu W, et al
Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study.
Breast Cancer Res Treat. 2008;107:123-32.
PubMed Related articles Abstract available

RAJPUT AB , Turbin DA, Cheang MC, Voduc DK, et al
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.
Breast Cancer Res Treat. 2008;107:249-57.
PubMed Related articles Abstract available

XU H , Ju D, Jarois T, Xie Y, et al
Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells.
Breast Cancer Res Treat. 2008;107:267-74.
PubMed Related articles Abstract available

BROEKS A , Braaf LM, Huseinovic A, Schmidt MK, et al
The spectrum of ATM missense variants and their contribution to contralateral breast cancer.
Breast Cancer Res Treat. 2008;107:243-8.
PubMed Related articles Abstract available

DUFRESNE A , Pivot X, Tournigand C, Facchini T, et al
Impact of chemotherapy beyond the first line in patients with metastatic breast cancer.
Breast Cancer Res Treat. 2008;107:275-9.
PubMed Related articles Abstract available

TICE JA , Feldman MD
Full-field digital mammography compared with screen-film mammography in the detection of breast cancer: rays of light through DMIST or more fog?
Breast Cancer Res Treat. 2008;107:157-65.
PubMed Related articles

KARAMOUZIS MV , Konstantinopoulos PA, Badra FA, Papavassiliou AG, et al
SUMO and estrogen receptors in breast cancer.
Breast Cancer Res Treat. 2008;107:195-210.
PubMed Related articles Abstract available

TAPIA T , Sanchez A, Vallejos M, Alvarez C, et al
ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
Breast Cancer Res Treat. 2008;107:281-8.
PubMed Related articles Abstract available

ELLSWORTH RE , Hooke JA, Love B, Kane JL, et al
Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors.
Breast Cancer Res Treat. 2008;107:259-65.
PubMed Related articles Abstract available

DIZDAR O , Dede DS, Bulut N, Altundag K, et al
Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines.
Breast Cancer Res Treat. 2008;107:303.
PubMed Related articles

IAKOVLEV VV , Goswami RS, Vecchiarelli J, Arneson NC, et al
Quantitative detection of circulating epithelial cells by Q-RT-PCR.
Breast Cancer Res Treat. 2008;107:145-54.
PubMed Related articles Abstract available

FOURNIER A , Berrino F, Clavel-Chapelon F
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.
Breast Cancer Res Treat. 2008;107:103-11.
PubMed Related articles Abstract available

BANERJEE B , Sharma S, Hegde S, Hande MP, et al
Analysis of telomere damage by fluorescence in situ hybridisation on micronuclei in lymphocytes of breast carcinoma patients after radiotherapy.
Breast Cancer Res Treat. 2008;107:25-31.
PubMed Related articles Abstract available

HIRSCH AE , Atencio DP, Rosenstein BS
Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.
Breast Cancer Res Treat. 2008;107:139-44.
PubMed Related articles Abstract available

VAN DER GROEP P , Hoelzel M, Buerger H, Joenje H, et al
Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer.
Breast Cancer Res Treat. 2008;107:41-7.
PubMed Related articles Abstract available

JOURNE F , Laurent G, Chaboteaux C, Nonclercq D, et al
Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
Breast Cancer Res Treat. 2008;107:49-61.
PubMed Related articles Abstract available

XU H , Washington S, Verderame MF, Manni A, et al
Activation of protein kinase A (PKA) signaling mitigates the antiproliferative and antiinvasive effects of alpha-difluoromethylornithine in breast cancer cells.
Breast Cancer Res Treat. 2008;107:63-70.
PubMed Related articles Abstract available

JAKUBOWSKA A , Cybulski C, Szymanska A, Huzarski T, et al
BARD1 and breast cancer in Poland.
Breast Cancer Res Treat. 2008;107:119-22.
PubMed Related articles Abstract available

WAKEFIELD CE , Meiser B, Homewood J, Peate M, et al
A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.
Breast Cancer Res Treat. 2008;107:289-301.
PubMed Related articles Abstract available

LISSOWSKA J , Gaudet MM, Brinton LA, Peplonska B, et al
Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status.
Breast Cancer Res Treat. 2008;107:113-7.
PubMed Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: